LIGAND PHARMACEUTICALS INCORPORATED Lessee, Operating Lease, Liability, Undiscounted Excess Amount
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $1.15 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-02-27
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.15M.
- 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.98M.
- 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2.24M.
- 2022-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $4.38M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-12-31 | $1.15M 10-K · filed 2026-02-27 |
| 2024-12-31 | $1.98M 10-K · filed 2025-02-28 |
| 2023-12-31 | $2.24M 10-K · filed 2024-02-29 |
| 2022-12-31 | $4.38M 10-K · filed 2023-02-28 |
| 2022-09-30 | $10.49M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $6.74M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $3.86M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $4.03M 10-K · filed 2022-02-28 |
| 2021-09-30 | $2.86M 10-Q · filed 2021-11-09 |
| 2020-12-31 | $1.13M 10-K · filed 2021-02-24 |
| 2019-12-31 | $2.65M 10-K · filed 2020-02-27 |
| 2019-09-30 | $2.73M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $2.86M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $1.38M 10-Q · filed 2019-05-09 |